HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Izabela Mlynarczuk Selected Research

Neoplasms (Cancer)

8/2005Tripeptide mimetics inhibit the 20 S proteasome by covalent bonding to the active threonines.
7/2002Synergistic interaction between highly specific cyclooxygenase-2 inhibitor, MF-tricyclic and lovastatin in murine colorectal cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Izabela Mlynarczuk Research Topics

Disease

2Neoplasms (Cancer)
08/2005 - 07/2002
1Colorectal Neoplasms (Colorectal Cancer)
07/2002
1Colonic Neoplasms (Colon Cancer)
07/2002

Drug/Important Bio-Agent (IBA)

1Pharmaceutical PreparationsIBA
08/2005
13- (3,4- difluorophenyl)- 4- (4- (methylsulfonyl)phenyl)- 2(5H)- furanoneIBA
07/2002
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2002
1Lovastatin (Mevacor)FDA LinkGeneric
07/2002